Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

GMT Capital Boosted Its Stake In $AXL

GMT Capital, managed by Thomas E. Claugus, recently revealed its 7.5% passive stake or 5.63 million shares in American Axle & Manufacturing Holdings Inc. (AXL). GMT Capital was AXL’s largest hedge fund stakeholder in the third quarter, and reported 4.01 million shares in AXL at that time. So now its position is up 40%. AXL has lost about 22% in 2011. The stock dropped to its 52-week low in early October. Now the stock is reaching $10 per share.

American Axle & Manufact. Holdings, Inc. (NYSE:AXL)

Beside GMT Capital, there are several hedge funds also held AXL in the third quarter. David Dreman’s Dreman Value Management had 2.92 million shares, while Cliff Asness’ AQR Capital Management doubled its position and had 1.18 million shares at the end of September.

GMT Capital is a private investment company, targeting on long-term absolute returns in Basic Materials, Technology, Services, Financial, Consumer Goods and some other sectors. The company had a 13F portfolio of $4.4 billion in the second quarter. Mr. Thomas E. Claugus is the Founder and President at GMT Capital. Before he found the GMT Capital in 1990, he acted as a manager for Europe of the polymers division of Rohm and Haas.

According to Google Finance, American Axle & Manufacturing Holdings, Inc. “manufactures, engineers, designs and validates driveline and drivetrain systems and related components and chassis modules for light trucks, sport utility vehicles (SUVs), passenger cars, crossover vehicles and commercial vehicles.”

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!